Safety, Tolerability and Efficacy of S-1226 in Cystic Fibrosis and Non CF Bronchiectasis

NCT03903913 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Cystic Fibrosis
Bronchiectasis

Interventions

DRUG: S-1226

Sponsor

SolAeroMed Inc.